HealthCare Ventures

edit

HealthCare Ventures is a leading venture capital firm specializing in life science industry investing. At HealthCare Ventures we concentrate our investment dollars on life science companies showing high growth potential. Since 1985, we have maintained a constant objective to support entrepreneurs and to generate above average returns for our limited partners.

Milestones

edit

• 
  HealthCare Ventures invested in PharmAthene. (7/27/09)
  Posted 9/28/09 at 2:44am
• 
  HealthCare Ventures invested in Xanodyne. (6/23/09)
  Posted 6/23/09 at 10:21am
• 
  HealthCare Ventures invested in VaxInnate. (6/14/09)
  Posted 6/16/09 at 8:28am
• 
  HealthCare Ventures invested in Seahorse Bioscience. (3/9/09)
  Posted 6/20/09 at 12:18am
• 
  HealthCare Ventures invested in Catalyst Biosciences. (12/3/08)
  Posted 6/23/09 at 10:50am
• 
  HealthCare Ventures invested in Proteostasis Therapeutics. (8/25/08)
  Posted 6/21/09 at 11:40pm
• 
  HealthCare Ventures invested in Trevena. (3/08)
  Posted 6/17/09 at 6:23pm

Investments

Videos

Sources

1. PharmAthene, Inc. Announces $19.3 Million Private Placement of Convertible Notes and Common Stock Warrants (ir.pharmathene.com) [edit]
2. Xanodyne Pharmaceuticals, Inc.: Series D $38M (onbiovc.com) [edit]
3. VaxInnate Corp., Series D $30M (onbiovc.com) [edit]
4. Seahorse Bioscience lands $6M, buys BioProcessors Corp (masshightech.com) [edit]
5. Catalyst Biosciences Raises $40 Million in Series C Financing (fiercebiotech.com) [edit]
6. Proteostasis Therapeutics Secures a $45 Million Series A Financing to Develop Proteostasis Regulator(TM) Drugs (reuters.com) [edit]
7. Trevena, Inc. Announces $24 Million Series A Financing (trevenainc.com) [edit]